참고문헌 (68)

1. 1 Mohty M de LH Ladaique P Faucher C Vey N Coso D Stoppa AM Gastaut JA Blaise D The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison Leukemia 2005 19 916 920 15843817 

   상세보기

2. 2 Poon LM Bassett R Jr Rondon G Hamdi A Qazilbash M Hosing C Jones RB Shpall EJ Popat UR Nieto Y Worth LL Cooper L De LM Champlin RE Kebriaei P Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia Bone Marrow Transplant 2013 48 666 670 23085830 

   상세보기

3. 3 Demirer T Barkholt L Blaise D Pedrazzoli P Aglietta M Carella AM Bay JO Arpaci F Rosti G Gurman G Niederwieser D Bregni M Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors Nat Clin Pract Oncol 2008 5 256 267 18398414 

   상세보기

4. 4 Dvorak CC Cowan MJ Hematopoietic stem cell transplantation for primary immunodeficiency disease Bone Marrow Transplant 2008 41 119 126 17968328 

   상세보기

5. 5 Warren EH Fujii N Akatsuka Y Chaney CN Mito JK Loeb KR Gooley TA Brown ML Koo KK Rosinski KV Ogawa S Matsubara A Appelbaum FR Riddell SR Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens Blood 2010 115 3869 3878 20071660 

   상세보기

6. 6 Blazar BR Murphy WJ Abedi M Advances in graft-versus-host disease biology and therapy Nat Rev Immunol 2012 12 443 458 22576252 

   상세보기

7. 7 Shlomchik WD Graft-versus-host disease Nat Rev Immunol 2007 7 340 352 17438575 

   상세보기

8. 8 Washington K Jagasia M Pathology of graft-versus-host disease in the gastrointestinal tract Hum Pathol 2009 40 909 917 19524102 

   상세보기

9. 9 Hill GR Ferrara JL The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation Blood 2000 95 2754 2759 10779417 

   상세보기

10. 10 Fukata M Vamadevan AS Abreu MT Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders Semin Immunol 2009 21 242 253 19748439 

    상세보기

11. 11 Heimesaat MM Nogai A Bereswill S Plickert R Fischer A Loddenkemper C Steinhoff U Tchaptchet S Thiel E Freudenberg MA Gobel UB Uharek L MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease Gut 2010 59 1079 1087 20639251 

    상세보기

12. 12 Marcellus DC Altomonte VL Farmer ER Horn TD Freemer CS Grant J Vogelsang GB Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease Blood 1999 93 66 70 9864147 

    상세보기

13. 13 Pai CC Chen M Mirsoian A Grossenbacher SK Tellez J Ames E Sun K Jagdeo J Blazar BR Murphy WJ Abedi M Treatment of chronic graft-versus-host disease with bortezomib Blood 2014 124 1677 1688 25009225 

    상세보기

14. 14 Rozendaal L Pals ST Gleichmann E Melief CJ Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease Clin Exp Immunol 1990 82 527 532 2148286 

    상세보기

15. 15 Wakae T Takatsuka H Seto Y Iwata N Mori A Okada M Fujimori Y Okamoto T Kakishita E Hara H Similarity between hepatic graft-versus-host disease and primary biliary cirrhosis Hematology 2002 7 305 310 12850818 

16. 16 Shono Y Shiratori S Kosugi-Kanaya M Ueha S Sugita J Shigematsu A Kondo T Hashimoto D Fujimoto K Endo T Nishio M Hashino S Matsuno Y Matsushima K Tanaka J Imamura M Teshima T Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation Biol Blood Marrow Transplant 2014 20 495 500 24374213 

    상세보기

17. 17 Silva R Morgado JM Freitas A Couceiro A Orfao A Regateiro F Paiva A Influence of pro- and anti-inflammatory cytokines in Th1 polarization after allogeneic stimulation Int J Biomed Sci 2005 1 46 52 23674953 

18. 18 Biedermann BC Sahner S Gregor M Tsakiris DA Jeanneret C Pober JS Gratwohl A Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease Lancet 2002 359 2078 2083 12086762 

19. 19 Jagasia MH Greinix HT Arora M Williams KM Wolff D Cowen EW Palmer J Weisdorf D Treister NS Cheng GS Kerr H Stratton P Duarte RF McDonald GB Inamoto Y Vigorito A Arai S Datiles MB Jacobsohn D Heller T Kitko CL Mitchell SA Martin PJ Shulman H Wu RS Cutler CS Vogelsang GB Lee SJ Pavletic SZ Flowers ME National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report Biol Blood Marrow Transplant 2015 21 389 401 25529383 

    상세보기

20. 20 Ferrara JL Deeg HJ Graft-versus-host disease N Engl J Med 1991 324 667 674 1994250 

    상세보기

21. 21 Reddy P Pathophysiology of acute graft-versus-host disease Hematol Oncol 2003 21 149 161 14735553 

    상세보기

22. 22 Ju JM Lee H Oh K Lee DS Choi EY Kinetics of IFN-gamma and IL-17 production by CD4 and CD8 T cells during acute graft-versus-host disease Immune Netw 2014 14 89 99 24851098 

23. 23 Ross WA Ghosh S Dekovich AA Liu S Ayers GD Cleary KR Lee JH Couriel D Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies Am J Gastroenterol 2008 103 982 989 18028511 

    상세보기

24. 24 Mai V Draganov PV Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health World J Gastroenterol 2009 15 81 85 19115471 

25. 25 Sender R Fuchs S Milo R Revised estimates for the number of human and bacteria cells in the body PLoS Biol 2016 14 e1002533 27541692 

    상세보기

26. 26 Savage DC Microbial ecology of the gastrointestinal tract Annu Rev Microbiol 1977 31 107 133 334036 

    상세보기

27. 27 Jenq RR Ubeda C Taur Y Menezes CC Khanin R Dudakov JA Liu C West ML Singer NV Equinda MJ Gobourne A Lipuma L Young LF Smith OM Ghosh A Hanash AM Goldberg JD Aoyama K Blazar BR Pamer EG van den Brink MR Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation J Exp Med 2012 209 903 911 22547653 

    상세보기

28. 28 Eriguchi Y Takashima S Oka H Shimoji S Nakamura K Uryu H Shimoda S Iwasaki H Shimono N Ayabe T Akashi K Teshima T Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of alpha-defensins Blood 2012 120 223 231 22535662 

29. 29 Beelen DW Elmaagacli A Muller KD Hirche H Schaefer UW Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial Blood 1999 93 3267 3275 10233878 

30. 30 Murphy S Nguyen VH Role of gut microbiota in graft-versus-host disease Leuk Lymphoma 2011 52 1844 1856 21663498 

    상세보기

31. 31 Schwab L Goroncy L Palaniyandi S Gautam S Triantafyllopoulou A Mocsai A Reichardt W Karlsson FJ Radhakrishnan SV Hanke K Schmitt-Graeff A Freudenberg M von Loewenich FD Wolf P Leonhardt F Baxan N Pfeifer D Schmah O Schonle A Martin SF Mertelsmann R Duyster J Finke J Prinz M Henneke P Hacker H Hildebrandt GC Hacker G Zeiser R Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage Nat Med 2014 20 648 654 24836575 

    상세보기

32. 32 Hill GR Crawford JM Cooke KR Brinson YS Pan L Ferrara JL Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines Blood 1997 90 3204 3213 9376604 

    상세보기

33. 33 Cooke KR Gerbitz A Crawford JM Teshima T Hill GR Tesolin A Rossignol DP Ferrara JL LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation J Clin Invest 2001 107 1581 1589 11413166 

    상세보기

34. 34 Holler E Cytokines, viruses, and graft-versus-host disease Curr Opin Hematol 2002 9 479 484 12394168 

    상세보기

35. 35 Brennan TV Lin L Huang X Cardona DM Li Z Dredge K Chao NJ Yang Y Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation Blood 2012 120 2899 2908 22760779 

    상세보기

36. 36 Imado T Iwasaki T Kitano S Satake A Kuroiwa T Tsunemi S Sano H The protective role of host Toll-like receptor-4 in acute graft-versus-host disease Transplantation 2010 90 1063 1070 20975627 

    상세보기

37. 37 Li H Matte-Martone C Tan HS Venkatesan S McNiff J Demetris AJ Jain D Lakkis F Rothstein D Shlomchik WD Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells J Immunol 2011 186 230 241 21098219 

    상세보기

38. 38 Calcaterra C Sfondrini L Rossini A Sommariva M Rumio C Menard S Balsari A Critical role of TLR9 in acute graft-versus-host disease J Immunol 2008 181 6132 6139 18941203 

    상세보기

39. 39 Taylor PA Ehrhardt MJ Lees CJ Panoskaltsis-Mortari A Krieg AM Sharpe AH Murphy WJ Serody JS Hemmi H Akira S Levy RB Blazar BR TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection Blood 2008 112 3508 3516 18614760 

    상세보기

40. 40 Spranger S Javorovic M Burdek M Wilde S Mosetter B Tippmer S Bigalke I Geiger C Schendel DJ Frankenberger B Generation of Th1-polarizing dendritic cells using the TLR7/8 agonist CL075 J Immunol 2010 185 738 747 20511554 

    상세보기

41. 41 Hemmi H Kaisho T Takeuchi O Sato S Sanjo H Hoshino K Horiuchi T Tomizawa H Takeda K Akira S Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nat Immunol 2002 3 196 200 11812998 

    상세보기

42. 42 Jasperson LK Bucher C Panoskaltsis-Mortari A Mellor AL Munn DH Blazar BR Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality Blood 2009 114 5062 5070 19828695 

    상세보기

43. 43 Lee WS Kim JY Won HJ Lee SM Suh YS Joo YD Lee JY Jang WH Kang SW Kang MS Park SG Choi IW Choi I Seo SK Effect of upregulated TLR2 expression from G-CSF-mobilized donor grafts on acute graft-versus-host disease Int Immunopharmacol 2015 29 488 493 26462591 

    상세보기

44. 44 Sivula J Cordova ZM Tuimala J Jaatinen T Partanen J Volin L Turpeinen H Toll-like receptor gene polymorphisms confer susceptibility to graft-versus-host disease in allogenic hematopoietic stem cell transplantation Scand J Immunol 2012 76 336 341 22703024 

    상세보기

45. 45 Xiao HW Luo Y Lai XY Shi JM Tan YM He JS Xie WZ Zheng WY Ye XJ Yu XH Cai Z Lin MF Huang H Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes Bone Marrow Transplant 2014 49 241 247 24121213 

    상세보기

46. 46 Lorenz E Schwartz DA Martin PJ Gooley T Lin MT Chien JW Hansen JA Clark JG Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation Biol Blood Marrow Transplant 2001 7 384 387 11529488 

    상세보기

47. 47 Akira S Takeda K Toll-like receptor signalling Nat Rev Immunol 2004 4 499 511 15229469 

    상세보기

48. 48 Takeda K Kaisho T Akira S Toll-like receptors Annu Rev Immunol 2003 21 335 376 12524386 

    상세보기

49. 49 Lim JY Lee YK Lee SE Ju JM Park G Choi EY Min CK Attenuation of hepatic graft-versus-host disease in allogeneic recipients of MyD88-deficient donor bone marrow Immune Netw 2015 15 125 134 26140044 

50. 50 Yamamoto M Sato S Hemmi H Hoshino K Kaisho T Sanjo H Takeuchi O Sugiyama M Okabe M Takeda K Akira S Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway Science 2003 301 640 643 12855817 

    상세보기

51. 51 Lim JY Lee YK Lee SE Ju JM Eom KS Kim YJ Chung NG Jeong DC Park G Choi EY Min CK MyD88 in donor bone marrow cells is critical for protection from acute intestinal graft-vs.-host disease Mucosal Immunol 2016 9 730 743 26442657 

    상세보기

52. 52 Gabrilovich DI Ostrand-Rosenberg S Bronte V Coordinated regulation of myeloid cells by tumours Nat Rev Immunol 2012 12 253 268 22437938 

    상세보기

53. 53 Crook KR Liu P Role of myeloid-derived suppressor cells in autoimmune disease World J Immunol 2014 4 26 33 25621222 

54. 54 Smith AR Reynolds JM Editorial: the contribution of myeloid-derived suppression to inflammatory disease J Leukoc Biol 2014 96 361 364 25183794 

    상세보기

55. 55 Chandra D Jahangir A Quispe-Tintaya W Einstein MH Gravekamp C Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice Br J Cancer 2013 108 2281 2290 23640395 

    상세보기

56. 56 Schmid M Zimara N Wege AK Ritter U Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice Eur J Immunol 2014 44 3295 3306 25142017 

    상세보기

57. 57 Terrazas LI Walsh KL Piskorska D McGuire E Harn DA Jr The schistosome oligosaccharide lacto-N-neotetraose expands Gr1(+) cells that secrete anti-inflammatory cytokines and inhibit proliferation of naive CD4(+) cells: a potential mechanism for immune polarization in helminth infections J Immunol 2001 167 5294 5303 11673545 

58. 58 Gabrilovich DI Nagaraj S Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 2009 9 162 174 19197294 

    상세보기

59. 59 Koehn BH Apostolova P Haverkamp JM Miller JS McCullar V Tolar J Munn DH Murphy WJ Brickey WJ Serody JS Gabrilovich DI Bronte V Murray PJ Ting JP Zeiser R Blazar BR GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells Blood 2015 126 1621 1628 26265697 

    상세보기

60. 60 Messmann JJ Reisser T Leithauser F Lutz MB Debatin KM Strauss G In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity Blood 2015 126 1138 1148 26185131 

    상세보기

61. 61 Kusmartsev S Eruslanov E Kubler H Tseng T Sakai Y Su Z Kaliberov S Heiser A Rosser C Dahm P Siemann D Vieweg J Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma J Immunol 2008 181 346 353 18566400 

    상세보기

62. 62 Ko JS Zea AH Rini BI Ireland JL Elson P Cohen P Golshayan A Rayman PA Wood L Garcia J Dreicer R Bukowski R Finke JH Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients Clin Cancer Res 2009 15 2148 2157 19276286 

    상세보기

63. 63 De SC Serafini P Marigo I Dolcetti L Bolla M Del SP Melani C Guiducci C Colombo MP Iezzi M Musiani P Zanovello P Bronte V Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination Proc Natl Acad Sci U S A 2005 102 4185 4190 15753302 

    상세보기

64. 64 Veltman JD Lambers ME van NM Hendriks RW Hoogsteden HC Aerts JG Hegmans JP COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function BMC Cancer 2010 10 464 20804550 

    상세보기

65. 65 Wu H Tao N Liu X Li X Tang J Ma C Xu X Shao H Hou B Wang H Qin Z Polysaccharide from Lentinus edodes inhibits the immunosuppressive function of myeloid-derived suppressor cells PLoS One 2012 7 e51751 23272159 

    상세보기

66. 66 Roth F De La Fuente AC Vella JL Zoso A Inverardi L Serafini P Aptamer-mediated blockade of IL4Ralpha triggers apoptosis of MDSCs and limits tumor progression Cancer Res 2012 72 1373 1383 22282665 

67. 67 Sawanobori Y Ueha S Kurachi M Shimaoka T Talmadge JE Abe J Shono Y Kitabatake M Kakimi K Mukaida N Matsushima K Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice Blood 2008 111 5457 5466 18375791 

    상세보기

68. 68 Sinha P Clements VK Fulton AM Ostrand-Rosenberg S Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells Cancer Res 2007 67 4507 4513 17483367 

    상세보기